Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 164

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Interventions for myopia control in children: a living systematic review and network meta-analysis

Open access
Lawrenson, John G, Shah, Rakhee, Huntjens, Byki, Downie, Laura E, Virgili, Gianni, Dhakal, Rohit, Verkicharla, Pavan K, Li, Dongfeng, Mavi, Sonia, Kernohan, Ashleigh, Li, Tianjing, Walline, Jeffrey J · 2023 · Cochrane Database of Systematic Reviews

Abstract

BACKGROUND: Myopia is a common refractive error, where elongation of the eyeball causes distant objects to appear blurred. The increasing prevalence of myopia is a growing global public health problem, in terms of rates of uncorrected refractive error and significantly, an increased risk of visual impairment due to myopia-related ocular morbidity. Since myopia is usually detected in children before 10 years of age and can progress rapidly, interventions to slow its progression need to be delivered in childhood. OBJECTIVES: To assess the comparative efficacy of optical, pharmacological and environmental interventions for slowing myopia progression in children using network meta-analysis (NMA). To generate a relative ranking of myopia control interventions according to their efficacy. To produce a brief economic commentary, summarising the economic evaluations assessing myopia control interventions in children. To maintain the currency of the evidence using a living systematic review approach. SEARCH METHODS: We searched CENTRAL (which contains the Cochrane Eyes and Vision Trials Register), MEDLINE; Embase; and three trials registers. The search date was 26 February 2022. SELECTION CRITERIA: We included randomised controlled trials (RCTs) of optical, pharmacological and environmental interventions for slowing myopia progression in children aged 18 years or younger. Critical outcomes were progression of myopia (defined as the difference in the change in spherical equivalent refraction (SER, dioptres (D)) and axial length (mm) in the intervention and control groups at one year or longer) and difference in the change in SER and axial length following cessation of treatment ('rebound'). DATA COLLECTION AND ANALYSIS: We followed standard Cochrane methods. We assessed bias using RoB 2 for parallel RCTs. We rated the certainty of evidence using the GRADE approach for the outcomes: change in SER and axial length at one and two years. Most comparisons were with inactive controls. MAIN RESULTS: We included 64 studies that randomised 11,617 children, aged 4 to 18 years. Studies were mostly conducted in China or other Asian countries (39 studies, 60.9%) and North America (13 studies, 20.3%). Fifty-seven studies (89%) compared myopia control interventions (multifocal spectacles, peripheral plus spectacles (PPSL), undercorrected single vision spectacles (SVLs), multifocal soft contact lenses (MFSCL), orthokeratology, rigid gas-permeable contact lenses (RGP); or pharmacological interventions (including high- (HDA), moderate- (MDA) and low-dose (LDA) atropine, pirenzipine or 7-methylxanthine) against an inactive control. Study duration was 12 to 36 months. The overall certainty of the evidence ranged from very low to moderate. Since the networks in the NMA were poorly connected, most estimates versus control were as, or more, imprecise than the corresponding direct estimates. Consequently, we mostly report estimates based on direct (pairwise) comparisons below. At one year, in 38 studies (6525 participants analysed), the median change in SER for controls was -0.65 D. The following interventions may reduce SER progression compared to controls: HDA (mean difference (MD) 0.90 D, 95% confidence interval (CI) 0.62 to 1.18), MDA (MD 0.65 D, 95% CI 0.27 to 1.03), LDA (MD 0.38 D, 95% CI 0.10 to 0.66), pirenzipine (MD 0.32 D, 95% CI 0.15 to 0.49), MFSCL (MD 0.26 D, 95% CI 0.17 to 0.35), PPSLs (MD 0.51 D, 95% CI 0.19 to 0.82), and multifocal spectacles (MD 0.14 D, 95% CI 0.08 to 0.21). By contrast, there was little or no evidence that RGP (MD 0.02 D, 95% CI -0.05 to 0.10), 7-methylxanthine (MD 0.07 D, 95% CI -0.09 to 0.24) or undercorrected SVLs (MD -0.15 D, 95% CI -0.29 to 0.00) reduce progression. At two years, in 26 studies (4949 participants), the median change in SER for controls was -1.02 D. The following interventions may reduce SER progression compared to controls: HDA (MD 1.26 D, 95% CI 1.17 to 1.36), MDA (MD 0.45 D, 95% CI 0.08 to 0.83), LDA (MD 0.24 D, 95% CI 0.17 to 0.31), pirenzipine (MD 0.41 D, 95% CI 0.13 to 0.69), MFSCL (MD 0.30 D, 95% CI 0.19 to 0.41), and multifocal spectacles (MD 0.19 D, 95% CI 0.08 to 0.30). PPSLs (MD 0.34 D, 95% CI -0.08 to 0.76) may also reduce progression, but the results were inconsistent. For RGP, one study found a benefit and another found no difference with control. We found no difference in SER change for undercorrected SVLs (MD 0.02 D, 95% CI -0.05 to 0.09). At one year, in 36 studies (6263 participants), the median change in axial length for controls was 0.31 mm. The following interventions may reduce axial elongation compared to controls: HDA (MD -0.33 mm, 95% CI -0.35 to 0.30), MDA (MD -0.28 mm, 95% CI -0.38 to -0.17), LDA (MD -0.13 mm, 95% CI -0.21 to -0.05), orthokeratology (MD -0.19 mm, 95% CI -0.23 to -0.15), MFSCL (MD -0.11 mm, 95% CI -0.13 to -0.09), pirenzipine (MD -0.10 mm, 95% CI -0.18 to -0.02), PPSLs (MD -0.13 mm, 95% CI -0.24 to -0.03), and multifocal spectacles (MD -0.06 mm

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/14651858.cd014758.pub2

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 426

  1. Adler, 2006, The possible effect of undercorrection on myopic progression in children, Clinical and Experimental Optometry, 89, 315, 10.1111/j.1444-0938.2006.00055.x · DOI · Paper page
  2. Anstice, 2011, Effect of dual-focus soft contact lens wear on axial myopia progression in children, Ophthalmology, 118, 1152, 10.1016/j.ophtha.2010.10.035 · DOI · Paper page
  3. Chia, 2012, Atropine for the treatment of childhood myopia: safety and efficacy of 0.5%, 0.1%, and 0.01% doses (Atropine for the treatment of myopia 2), Ophthalmology, 119, 347, 10.1016/j.ophtha.2011.07.031 · DOI · Paper page
  4. Chia, 2014, Atropine for the treatment of childhood myopia: changes after stopping atropine 0.01%, 0.1% and 0.5%, American Journal of Ophthalmology, 157, 451, 10.1016/j.ajo.2013.09.020 · DOI · Paper page
  5. Chia, 2013, Full-field electroretinogram findings in children in the Atropine treatment for myopia (ATOM2) study, Documenta Ophthalmologica. Advances in Ophthalmology, 126, 177, 10.1007/s10633-012-9372-8 · doi:10.1007/s10633-012-9372-8
  6. Chia, 2016, Five-year clinical trial on atropine for the treatment of myopia 2: myopia control with atropine 0.01% eyedrops, Ophthalmology, 123, 391, 10.1016/j.ophtha.2015.07.004 · DOI · Paper page
  7. Chia, 2011, Full-field electroretinogram findings in myopic children on topical atropine, Documenta Ophthalmologica. Advances in Ophthalmology, 123 Suppl 1, 42
  8. Chua, 2006, Establishing an optimal dose of atropine for slowing progression of childhood myopia, Ophthalmic and Physiological Optics, 26, 29
  9. Chia, 2009, Effect of topical atropine on astigmatism, British Journal of Ophthalmology, 93, 799, 10.1136/bjo.2008.147421 · doi:10.1136/bjo.2008.147421
  10. Chua, 2006, Atropine for the treatment of childhood myopia, Ophthalmology, 113, 2285, 10.1016/j.ophtha.2006.05.062 · DOI · Paper page
  11. Kumaran, 2015, Analysis of changes in refraction and biometry of atropine- and placebo-treated eyes, Investigative Ophthalmology and Visual Science, 56, 5650, 10.1167/iovs.14-14716 · doi:10.1167/iovs.14-14716
  12. Loh, 2015, Risk factors for progressive myopia in the atropine therapy for myopia study, American Journal of Ophthalmology, 159, 945, 10.1016/j.ajo.2015.01.029 · doi:10.1016/j.ajo.2015.01.029
  13. Luu, 2005, Multifocal electroretinogram in children on atropine treatment for myopia, British Journal of Ophthalmology, 89, 151, 10.1136/bjo.2004.045526 · doi:10.1136/bjo.2004.045526
  14. Tong, 2009, Atropine for the treatment of childhood myopia: effect on myopia progression after cessation of atropine, Ophthalmology, 116, 572, 10.1016/j.ophtha.2008.10.020 · doi:10.1016/j.ophtha.2008.10.020
  15. Bao, 2022, Myopia control with spectacle lenses with aspherical lenslets: a 2-year randomized clinical trial, British Journal of Ophthalmology, 106, 1171
  16. Bao J Yang A Huang Y Li X Yang A Lim W One-year myopia control efficacy of spectacle lenses with aspherical lenslets Investigative Ophthalmology and Visual Science 2021 62 8 2888 · doi:10.1136/bjophthalmol-2020-318367
  17. Bian S Liu H Lin J A randomized-controlled clinical study of one-year outcome between orthokeratology contact lens wear and glasses wear in myopic children Chinese Journal of Experimental Ophthalmology 2020 38 2 121 7
  18. Walline JJ Walker MK Mutti DO Jones-Jordan LA Sinnott LT Giannoni AG Effect of high add power, medium add power, or single-vision contact lenses on myopia progression in children: the BLINK randomized clinical trial JAMA 2020 324 6 571 80 · DOI · Paper page
  19. Chamberlain P Logan N Peixoto-de-Matos S Young G Further comparison of myopia progression in new and established myopia control treatment (MiSight) groups Contact Lens and Anterior Eye 2019 42 6 Suppl e16 · doi:10.1016/j.clae.2019.10.055
  20. Chamberlain P Bradley A Arumugam B McNally J Logan NS Long-term effect of dual-focus conact lenses on myopia progression in children: a 6-year multicentre clinical trial Optometry and Vision Science 2022 99 3 204 12 · DOI
  21. Chamberlain P Peixoto-de-Matos SC Logan NS Ngo C Jones D Young G A 3-year randomized clinical trial of MiSight lenses for myopia control Optometry and Vision Science 2019 96 8 556 67 · DOI · Paper page
  22. Logan N Chamberlain P Hunt C Young G Visual acuity, vision performance acceptability and subjective over-refraction in myopic children wearing dual-focus contact lenses Contact Lens and Anterior Eye 2021 44 1 Suppl 1 e21 · doi:10.1016/j.clae.2020.12.070
  23. Woods J Jones D Jones L Jones S Hunt C Chamberlain P Ocular health of children wearing daily disposable contact lenses over a 6-year period Contact Lens and Anterior Eye 2021 44 4 101381 · doi:10.1016/j.clae.2020.11.011
  24. Charm, 2013, High myopia-partial reduction ortho-k: a 2-year randomized study, Optometry and Vision Science, 90, 530, 10.1097/OPX.0b013e318293657d · DOI · Paper page
  25. Charm, 2013, High myopia-partial reduction orthokeratology (HM-PRO): study design, Contact Lens and Anterior Eye, 36, 164, 10.1016/j.clae.2013.02.012 · doi:10.1016/j.clae.2013.02.012
  26. Charm, 2011, High myopia-partial reduction orthokeratology (HM-PRO) study: recruitment and one year result, Contact Lens and Anterior Eye, 34, S3, 10.1016/S1367-0484(11)60013-1 · doi:10.1016/s1367-0484(11)60013-1
  27. Cheng, 2010, Randomized trial of effect of bifocal and prismatic bifocal spectacles on myopic progression: two-year results, Archives of Ophthalmology, 128, 12, 10.1001/archophthalmol.2009.332 · DOI
  28. Cheng, 2014, Effect of bifocal and prismatic bifocal spectacles on myopia progression in children: three-year results of a randomized clinical trial, JAMA Ophthalmology, 132, 258, 10.1001/jamaophthalmol.2013.7623 · DOI · Paper page
  29. Cheng, 2016, Soft contact lenses with positive spherical aberration for myopia control, Optometry and Vision Science, 93, 353, 10.1097/OPX.0000000000000773 · DOI
  30. Chung, 2002, Undercorrection of myopia enhances rather than inhibits myopia progression, Vision Research, 42, 2555, 10.1016/S0042-6989(02)00258-4 · DOI · Paper page
  31. Jones-Jordan, 2010, Gas permeable and soft contact lens wear in children, Optometry and Vision Science, 87, 414, 10.1097/OPX.0b013e3181dc9a04 · DOI
  32. Walline, 2004, A randomized trial of the effects of rigid contact lenses on myopia progression, Archives of Ophthalmology, 122, 1760, 10.1001/archopht.122.12.1760 · DOI · Paper page
  33. Walline, 2006, The contact lens and myopia progression (CLAMP) study, Ophthalmic and Physiological Optics, 26, 29
  34. Walline, 2003, Use of a run-in period to decrease loss to follow-up in the Contact lens and myopia progression (CLAMP) study, Controlled Clinical Trials, 24, 711, 10.1016/S0197-2456(03)00097-7 · doi:10.1016/s0197-2456(03)00097-7
  35. Walline, 2001, The contact lens and myopia progression (CLAMP) study: design and baseline data, Optometry and Vision Science, 78, 223, 10.1097/00006324-200104000-00011 · doi:10.1097/00006324-200104000-00011
  36. Walline JJ Mutti DO Jones LA Zadnik K Baseline characteristics of the contact lens and myopia progression (CLAMP) study American Academy of Optometry 2000 213 · doi:10.1097/00006324-200012001-00341
  37. Correction of Myopia Evaluation Trial 2 Study Group for the Pediatric Eye Disease Investigator Group, 2011, Progressive-addition lenses versus single-vision lenses for slowing progression of myopia in children with high accommodative lag and near esophoria, Investigative Ophthalmology and Visual Science, 52, 2749, 10.1167/iovs.10-6631 · doi:10.1167/iovs.10-6631
  38. Deng, 2014, Limited change in anisometropia and aniso-axial length over 13 years in myopic children enrolled in the Correction of Myopia Evaluation Trial, Investigative Ophthalmology and Visual Science, 55, 2097, 10.1167/iovs.13-13675 · doi:10.1167/iovs.13-13675
  39. Dias, 2005, Evaluating the self-esteem of myopic children over a three-year period: the COMET experience, Optometry and Vision Science, 82, 338, 10.1097/01.OPX.0000159365.16184.BF · DOI
  40. Dias, 2002, The relationship between self-esteem of myopic children and ocular and demographic characteristics, Optometry and Vision Science, 79, 688, 10.1097/00006324-200211000-00006 · doi:10.1097/00006324-200211000-00006
  41. Dias, 2013, Myopia, contact lens use and self-esteem, Ophthalmic & Physiological Optics, 33, 573, 10.1111/opo.12080 · DOI
  42. Dias, 2005, Reasons for high retention in pediatric clinical trials: comparison of participant and staff responses in the Correction of Myopia Evaluation Trial, Clinical Trials, 2, 443, 10.1191/1740774505cn113oa · DOI
  43. Dong, 2007, Myopia stabilization in the Correction of Myopia Evaluation Trial (COMET) cohort, Investigative Ophthalmology & Visual Science, 48, ARVO E
  44. Dong, 2006, Use of the Gompertz function to describe the course of myopia progression and stabilization in the Correction of Myopia Evaluation Trial (COMET), Optometry and Vision Science, 83, E
  45. Dong, 2006, Evaluating masking in a randomized, double-masked clinical trial in children with myopia, Optometry and Vision Science, 83, 46, 10.1097/01.opx.0000195564.38235.39 · DOI
  46. Fern, 2012, Intraocular pressure and central corneal thickness in the COMET cohort, Optometry and Vision Science, 89, 1225, 10.1097/OPX.0b013e3182639fc7 · doi:10.1097/opx.0b013e3182639fc7
  47. Gwiazda, 2011, Association of education and occupation with myopia in COMET parents, Optometry and Vision Science, 88, 1045, 10.1097/OPX.0b013e31822171ad · doi:10.1097/opx.0b013e31822171ad
  48. Gwiazda, 2014, Seasonal variations in the progression of myopia in children enrolled in the Correction of Myopia Evaluation Trial, Investigative Ophthalmology & Visual Science, 55, 752, 10.1167/iovs.13-13029 · DOI
  49. Gwiazda, 2007, Factors associated with high myopia after 7 years of follow-up in the Correction of Myopia Evaluation Trial (COMET) cohort, Ophthalmic Epidemiology, 14, 230, 10.1080/01658100701486459 · DOI
  50. Gwiazda, 2003, A randomized clinical trial of progressive addition lenses versus single vision lenses on the progression of myopia in children, Investigative Ophthalmology and Visual Science, 44, 1492, 10.1167/iovs.02-0816 · DOI · Paper page
  51. Gwiazda, 2002, Baseline refractive and ocular component measures of children enrolled in the Correction of Myopia Evaluation Trial (COMET), Investigative Ophthalmology and Visual Science, 43, 314
  52. Gwiazda, 2016, Longitudinal changes in lens thickness in myopic children enrolled in the Correction of Myopia Evaluation Trial (COMET), Current Eye Research, 41, 492
  53. Gwiazda, 2004, Baseline accommodation and related risk factors associated with myopia progression and their interaction with treatment in COMET children, Investigative Ophthalmology and Visual Science, 45, ARVO E
  54. Gwiazda, 2004, Accommodation and related risk factors associated with myopia progression and their interaction with treatment in COMET children, Investigative Ophthalmology and Visual Science, 45, 2143, 10.1167/iovs.03-1306 · DOI · Paper page
  55. Harb, 2012, Factors associated with macular thickness in the COMET myopic cohort, Optometry and Vision Science, 89, 620, 10.1097/OPX.0b013e318251293a · doi:10.1097/opx.0b013e318251293a
  56. Harb, 2015, Choroidal thickness profiles in myopic eyes of young adults in the Correction of Myopia Evaluation Trial cohort, American Journal of Ophthalmology, 160, 62, 10.1016/j.ajo.2015.04.018 · DOI
  57. Hardy, 2013, Myopia stabilization and associated factors among participants in the Correction of Myopia Evaluation Trial (COMET), Investigative Ophthalmology and Visual Science, 54, 7871, 10.1167/iovs.13-12403 · DOI · Paper page
  58. Hussein, 2001, Reliability of measurements of phoria and accommodation in the Correction of Myopia Evaluation Trial (COMET), Investigative Ophthalmology & Visual Science, 42, ARVO E
  59. Hyman, 2005, Relationship of age, sex, and ethnicity with myopia progression and axial elongation in the Correction of Myopia Evaluation Trial, Archives of Ophthalmology, 123, 977, 10.1001/archopht.123.7.977 · DOI · Paper page
  60. Hyman, 2001, The Correction of Myopia Evaluation Trial (COMET): design and general baseline characteristics, Controlled Clinical Trials, 22, 573, 10.1016/S0197-2456(01)00156-8 · DOI
  61. Hyman, 2004, The Correction of Myopia Evaluation Trial: lessons from the study design, Annals of the Academy of Medicine Singapore, 33, 44, 10.47102/annals-acadmedsg.V33N1p44 · doi:10.47102/annals-acadmedsg.v33n1p44
  62. Hyman, 1998, Validity of cycloplegic autorefraction and axial length measurements in a clinical trial, Investigative Ophthalmology and Visual Science, 39, S4348
  63. Kowalski, 2005, Adaptability of myopic children to progressive addition lenses with a modified fitting protocol in the Correction of Myopia Evaluation trial (COMET), Optometry and Vision Science, 82, 328, 10.1097/01.OPX.0000159360.88324.01 · DOI
  64. Kurtz, 2007, Role of parental myopia in the progression of myopia and its interaction with treatment in COMET children, Investigative Ophthalmology and Visual Science, 48, 562, 10.1167/iovs.06-0408 · doi:10.1167/iovs.06-0408
  65. Kurtz D Manny R Hussein M COMET Group Reliability of ocular components measured by A-scan in children Optometry and Vision Science 2000 S286 · doi:10.1097/00006324-200012001-00476
  66. Kurtz, 2004, Variability of the ocular component measurements in children using A-scan ultrasonography, Optometry and Vision Science, 81, 35, 10.1097/00006324-200401000-00008 · doi:10.1097/00006324-200401000-00008
  67. Manny, 2008, IOP, myopic progression and axial length in a COMET subgroup, Optometry and Vision Science, 85, 97, 10.1097/OPX.0b013e3181622633 · doi:10.1097/opx.0b013e3181622633
  68. Manny, 2003, Repeatability of ETDRS visual acuity in children, Investigative Ophthalmology and Visual Science, 44, 3294, 10.1167/iovs.02-1199 · DOI
  69. Manny RE Hussein M Gwiazda J Reliability of ETDRS visual acuity (VA) in the Correction of Myopia Evaluation Trial (COMET) American Academy of Optometry 2000 279 · doi:10.1097/00006324-200012001-00463
  70. Manny, 2001, Tropicamide (1%): an effective cycloplegic agent for myopic children, Investigative Ophthalmology and Visual Science, 42, 1728
  71. Marsh-Tootle, 1999, Refractive, phoria, and axial measures at baseline in children enrolled in the Correction of Myopia Evaluation Trial (COMET), Investigative Ophthalmology and Visual Science, 40, S3992
  72. Marsh-Tootle, 2009, Myopia progression in children wearing spectacles vs. switching to contact lenses, Optometry and Vision Science, 86, 741, 10.1097/OPX.0b013e3181a6a250 · doi:10.1097/opx.0b013e3181a6a250
  73. Norton, 2008, Longitudinal changes in lens thickness in myopic children enrolled in the Correction of Myopia Evaluation Trial (COMET), Investigative Ophthalmology and Visual Science, 49, ARVO E
  74. Scheiman, 2016, Longitudinal changes in corneal curvature and its relationship to axial length in the Correction of Myopia Evaluation Trial (COMET) cohort, Journal of Optometry, 9, 13, 10.1016/j.optom.2015.10.003 · DOI
  75. Scheiman, 2014, Visual activity and its association with myopia stabilisation, Ophthalmic and Physiological Optics, 34, 353, 10.1111/opo.12111 · DOI
  76. Aller, 2016, Myopia control with bifocal contact lenses: a randomized clinical trial, Optometry and Vision Science, 93, 344, 10.1097/OPX.0000000000000808 · doi:10.1097/opx.0000000000000808
  77. Aller, 2006, Results of a one-year prospective clinical trial (CONTROL) of the use of bifocal soft contact lenses to control myopia progression, Ophthalmic and Physiological Optics, 26 Suppl 1, 8
  78. Aller TA Design of a prospective clinical trial of the use of bifocal soft contact lenses to control myopia progression (CONTROL) 10th International Myopia Conference 2004
  79. Cui, 2021, Safety and efficacy of 0.02% and 0.01% atropine on controlling myopia progression: a 2-year clinical trial, Scientific Reports, 11, 22267, 10.1038/s41598-021-01708-2 · doi:10.1038/s41598-021-01708-2
  80. Fu, 2021, Risk factors for rapid axial length elongation with low concentration atropine for myopia control, Scientific Reports, 11, 11729, 10.1038/s41598-021-88719-1 · doi:10.1038/s41598-021-88719-1
  81. Qin, 2021, Comparison of myopia progression between different concentrations and application frequencies of atropine eye drops in children, Chinese Journal of Experimental Ophthalmology, 39, 423
  82. Lam, 2011, Randomised clinical trial of myopia control in myopic schoolchildren using the defocus incorporated soft contact (DISC) lens, Optometry and Vision Science, 88, 444
  83. Lam, 2014, Defocus incorporated soft contact (DISC) lens slows myopia progression in Hong Kong Chinese schoolchildren: a 2-year randomised clinical trial, British Journal of Ophthalmology, 98, 40, 10.1136/bjophthalmol-2013-303914 · DOI · Paper page
  84. Edwards, 2002, The Hong Kong progressive lens myopia control study: study design and main findings, Investigative Ophthalmology and Visual Science, 43, 2852
  85. Fujikado, 2014, Effect of low-addition soft contact lenses with decentered optical design on myopia progression in children: a pilot study, Clinical Ophthalmology, 8, 1947, 10.2147/OPTH.S66884 · doi:10.2147/opth.s66884
  86. Fulk, 1996, Can bifocals slow myopia progression?, Journal of the American Optometric Association, 67, 749
  87. Fulk, 2003, The effect of changing from glasses to soft contact lenses on myopia progression in adolescents, Ophthalmic and Physiological Optics, 23, 71, 10.1046/j.1475-1313.2003.00094.x · doi:10.1046/j.1475-1313.2003.00094.x
  88. Fulk, 1998, A 3-year clinical trial of bifocals in children with near point esophoria: myopia progression during the first year, Investigative Ophthalmology and Visual Science, 39, S2982
  89. Fulk, 1997, A 3-year clinical trial of bifocals to slow myopia progression in children with near-point esophoria: baseline characteristics, Investigative Ophthalmology and Visual Science, 38, S5404
  90. Fulk, 1999, A clinical trial of bifocals in children: myopia progression after two years, Investigative Ophthalmology and Visual Science, 40, S3665
  91. Fulk, 2002, A randomized clinical trial of bifocal glasses for myopic children with esophoria: results after 54 months, Optometry, 73, 470
  92. Fulk, 2000, A randomized trial of the effect of single-vision vs. bifocal lenses on myopia progression in children with esophoria, Optometry and Vision Science, 77, 395, 10.1097/00006324-200008000-00006 · DOI
  93. Fulk, 1998, Baseline characteristics in the Myopia Progression Study, a clinical trial of bifocals to slow myopia progression, Optometry and Vision Science, 75, 485, 10.1097/00006324-199807000-00016 · doi:10.1097/00006324-199807000-00016
  94. Fulk, 2002, Progression of childhood myopia in soft contact lenses and glasses, Investigative Ophthalmology and Visual Science, 43, ARVO E
  95. Fulk, 2002, Seasonal variation in myopia progression and ocular elongation, Optometry and Vision Science, 79, 46, 10.1097/00006324-200201000-00012 · doi:10.1097/00006324-200201000-00012
  96. Garcia-Del Valle, 2021, Efficacy and safety of a soft contact lens to control myopia progression, Clinical and Experimental Optometry, 104, 14, 10.1111/cxo.13077 · DOI
  97. Guo, 2021, One-year results of the Variation of Orthokeratology Lens Treatment Zone (VOLTZ) study: a prospective randomised clinical trial, Ophthalmic and Physiological Optics, 41, 702, 10.1111/opo.12834 · doi:10.1111/opo.12834
  98. Han, 2018, A comparison of the effects of orthokeratology lens, Medcall lens, and ordinary frame glasses on the accommodative response in myopic children, Eye and Contact Lens, 44, 268, 10.1097/ICL.0000000000000390 · doi:10.1097/icl.0000000000000390
  99. Han, 2019, Combination with different anticholinergic eyedrops for the treatment of children myopia, National Medical Journal of China, 99, 1859
  100. Fujiwara, 2012, Seasonal variation in myopia progression and axial elongation: an evaluation of Japanese children participating in a myopia control trial, Japanese Journal of Ophthalmology, 56, 401, 10.1007/s10384-012-0148-1 · DOI
  101. Hasebe, 2005, Downward deviation of progressive addition lenses in a myopia control trial, Ophthalmic and Physiological Optics, 25, 310, 10.1111/j.1475-1313.2005.00301.x · doi:10.1111/j.1475-1313.2005.00301.x
  102. Hasebe, 2005, Myopia control trial with progressive addition lenses in Japanese schoolchildren: baseline measures of refraction, accommodation, and heterophoria, Japanese Journal of Ophthalmology, 49, 23, 10.1007/s10384-004-0131-6 · doi:10.1007/s10384-004-0131-6
  103. Hasebe, 2008, Effect of progressive addition lenses on myopia progression in Japanese children: a prospective, randomized, double-masked, crossover trial, Investigative Ophthalmology and Visual Science, 49, 2781, 10.1167/iovs.07-0385 · DOI
  104. Hasebe, 2002, A clinical trial to evaluate progressive addition lenses on myopia control. Study design, Japanese Journal of Vision Science, 23, 63
  105. Nakatsuka, 2004, Assessment of downward deviation of progressive addition lenses in a myopia control study, Investigative Ophthalmology and Visual Science, 45, ARVO E
  106. Suemaru, 2008, Visual symptoms and compliance with spectacle wear in myopic children: double-masked comparison between progressive addition lenses and single vision lenses, Acta Medica Okayama, 62, 109
  107. Hasebe, 2014, Myopia control with positively aspherized progressive addition lenses: a 2-year, multicenter, randomized, controlled trial, Investigative Ophthalmology and Visual Science, 55, 7177, 10.1167/iovs.12-11462 · doi:10.1167/iovs.12-11462
  108. Hieda O Hiraoka T Fujikado T Ishiko S Hasebe S Torii H Efficacy and safety of 0.01% atropine for prevention of childhood myopia in a 2-year randomized placebo-controlled study Japanese Journal of Ophthalmology 2021 65 3 315 25 · doi:10.1007/s10384-021-00822-y
  109. Grosvenor, 1985, The Houston Myopia Control Study: a preliminary report by the patient care team, Journal of the American Optometric Association, 56, 636
  110. Grosvenor, 1987, Houston Myopia Control Study: a randomized clinical trial. Part II. Final report by the patient care team, American Journal of Optometry and Physiological Optics, 64, 482, 10.1097/00006324-198707000-00002 · DOI
  111. Young, 1985, Houston Myopia Control Study: a randomized clinical trial. Part I. Background and design of the study, American Journal of Optometry and Physiological Optics, 62, 605, 10.1097/00006324-198509000-00005 · doi:10.1097/00006324-198509000-00005
  112. Jakobsen, 2022, Control of myopia using orthokeratology lenses in Scandinavian children aged 6 to 12 years. Eighteen-month data from the Danish randomized study: Clinical Study of Near-sightedness; Treatment with Orthokeratology Lenses (CONTROL study), Acta Ophthalmologica, 100, 175, 10.1111/aos.14911 · doi:10.1111/aos.14911
  113. Jensen, 1991, Myopia progression in young school children. A prospective study of myopia progression and the effect of a trial with bifocal lenses and beta blocker eye drops, Acta Ophthalmologica, 200, 1
  114. Jensen, 1988, Timolol maleate in the control of myopia. A preliminary report, Acta Ophthalmologica, 185, 128, 10.1111/j.1755-3768.1988.tb02686.x · doi:10.1111/j.1755-3768.1988.tb02686.x
  115. Chew, 1997, RGP contact lenses in the control of myopia progression, Investigative Ophthalmology and Visual Science, 38, S5402
  116. Katz, 2003, A randomized trial of rigid gas permeable contact lenses to reduce progression of children's myopia, American Journal of Ophthalmology, 136, 82, 10.1016/S0002-9394(03)00106-5 · doi:10.1016/s0002-9394(03)00106-5
  117. Kinoshita, 2020, Efficacy of combined orthokeratology and 0.01% atropine solution for slowing axial elongation in children with myopia: a 2-year randomised trial, Scientific Reports, 10, 12750, 10.1038/s41598-020-69710-8 · doi:10.1038/s41598-020-69710-8
  118. Koomson, 2016, Relationship between reduced accommodative lag and myopia progression, Optometry and Vision Science, 93, 683, 10.1097/OPX.0000000000000867 · doi:10.1097/opx.0000000000000867
  119. Lam CS Tang WC Lee PH Zhang HY Qi H Hasegawa K Myopia control effect of defocus incorporated multiple segments (DIMS) spectacle lens in Chinese children: results of a 3-year follow-up study British Journal of Ophthalmology 2021 106 8 1110 4 · doi:10.1136/bjophthalmol-2020-317664
  120. Lam, 2020, Defocus incorporated multiple segments (DIMS) spectacle lenses slow myopia progression: a 2-year randomised clinical trial, British Journal of Ophthalmology, 104, 363, 10.1136/bjophthalmol-2018-313739 · doi:10.1136/bjophthalmol-2018-313739
  121. Li, 2020, Differential effects on ocular biometrics by 0.05%, 0.025%, and 0.01% atropine: Low-concentration Atropine for Myopia Progression study, Ophthalmology, 127, 1603, 10.1016/j.ophtha.2020.06.004 · doi:10.1016/j.ophtha.2020.06.004
  122. Li, 2019, Effect of 0.05%, 0.025%, and 0.01% atropine eye drops on corneal parameters over one year: Low-concentration Atropine for Myopia Progression (LAMP) study, Investigative Ophthalmology and Visual Science, 60, ARVO E
  123. Li, 2021, Age effect on treatment responses to 0.05%, 0.025%, and 0.01% atropine: Low-concentration Atropine for Myopia Progression study, Ophthalmology, 128, 1180, 10.1016/j.ophtha.2020.12.036 · DOI
  124. Yam, 2019, Low-concentration Atropine for Myopia Progression (LAMP) study phase 2: 0.05% atropine remained the best concentration among 0.05%, 0.025%, and 0.01% atropine over 2 years, Investigative Ophthalmology and Visual Science, 60, ARVO E
  125. Yam, 2022, The association of choroidal thickening by atropine with treatment effects for myopia: two-year clinical trial of the LAMP study, American Journal of Ophthalmology ., 237, 130, 10.1016/j.ajo.2021.12.014 · doi:10.1016/j.ajo.2021.12.014
  126. Yam, 2019, Low-concentration Atropine for Myopia Progression (LAMP) study: a randomized, double-blinded, placebo-controlled trial of 0.05%, 0.025%, and 0.01% atropine eye drops in myopia control, Ophthalmology, 126, 113, 10.1016/j.ophtha.2018.05.029 · DOI · Paper page
  127. Yam, 2020, Two-year clinical trial of the Low-concentration Atropine for Myopia Progression (LAMP) study: phase 2 report, Ophthalmology, 127, 910, 10.1016/j.ophtha.2019.12.011 · DOI · Paper page
  128. Yam, 2022, Three-year clinical trial of low-concentration atropine for myopia progression study: continued versus washout: phase 3 reportYam JC, Zhang XJ, Zhang Y, Wang YM, Tang SM, Li FF, et al, Ophthalmology, 129, 308, 10.1016/j.ophtha.2021.10.002 · DOI · Paper page
  129. Lu, 2015, Clinical effect of the midperiphery additional designed lenses combined adjustment training on myopia in childhood, International Eye Science, 15, 1960
  130. Lyu, 2020, Regimen study of high myopia-partial reduction orthokeratology, Eye and Contact Lens, 46, 141, 10.1097/ICL.0000000000000629 · doi:10.1097/icl.0000000000000629
  131. Hsiao CK Chen CJ Shih YF Lin LL Hung PT Yao CL Design and statistical analysis for the Myopia Intervention Trial in Taiwan Lin LLK Shih YF Hung PT Myopia Updates II, 7th International Conference on Myopia, Taipei, Taiwan, Nov-Dec, 1998 Springer-Verlag 2000 161 4 · doi:10.1007/978-4-431-66917-3_40
  132. Hsiao, 2005, Inference of nested variance components in a longitudinal myopia intervention trial, Statistics in Medicine, 24, 3251, 10.1002/sim.2211 · DOI
  133. Shih, 2001, An intervention trial on efficacy of atropine and multi-focal glasses in controlling myopic progression, Acta Ophthalmologica Scandinavica, 79, 233, 10.1034/j.1600-0420.2001.790304.x · DOI · Paper page
  134. Moriche-Carretero, 2021, Myopia progression and axial elongation in Spanish children: efficacy of atropine 0.01% eye-drops, Journal Francais d'Ophtalmologie, 44, 1499, 10.1016/j.jfo.2021.07.005 · doi:10.1016/j.jfo.2021.07.005
  135. Hemminki, 1987, Prevention of myopic progress by glasses. Study design and the first-year results of a randomized trial among schoolchildren, American Journal of Optometry and Physiological Optics, 64, 611, 10.1097/00006324-198708000-00008 · DOI
  136. Pärssinen, 1989, Effect of spectacle use and accommodation on myopic progression: final results of a three-year randomised clinical trial among schoolchildren, British Journal of Ophthalmology, 73, 547, 10.1136/bjo.73.7.547 · DOI
  137. Pärssinen, 1988, Spectacle-use, bifocals and prevention of myopic progression. The two-years results of a randomized trial among schoolchildren, Acta Ophthalmologica, 185, 156, 10.1111/j.1755-3768.1988.tb02698.x · DOI
  138. Pärssinen, 2015, Astigmatism among myopics and its changes from childhood to adult age: a 23-year follow-up study, Acta Ophthalmologica, 93, 276, 10.1111/aos.12572 · DOI
  139. Pärssinen, 2017, What is the influence of parents' myopia on their children's myopic progression? A 22-year follow-up study, Acta Ophthalmologica, 94, 579, 10.1111/aos.13043 · DOI
  140. Pärssinen, 1993, Myopia and myopic progression among schoolchildren: a three-year follow-up study, Investigative Ophthalmology and Visual Science, 34, 2794
  141. Pärssinen, 1991, Astigmatism and school myopia, Acta Ophthalmologica, 69, 786, 10.1111/j.1755-3768.1991.tb02061.x · DOI
  142. Pärssinen, 1993, Corneal refraction and topography in school myopia, CLAO Journal, 19, 69
  143. Pärssinen TO Long-term connection of myopic progression with different background variables Lin LL Shih YF Hung PT Myopia Updates II: 7th International Conference on Myopia, Taipei, Taiwan, 1998 Springer-Verlag 2000 21 3 · DOI
  144. Pärssinen TO Progression of school myopia from its onset at the mean age of 10.9 years: 13-year follow-up study Lin LLK Shih YF Hung PT Myopia Updates II: 7th International Conference on Myopia, Taipei, Taiwan, 1998 Springer-Verlag 2000 25 8 · doi:10.1007/978-4-431-66917-3_6
  145. Bartlett, 2003, A tolerability study of pirenzepine ophthalmic gel in myopic children, Journal of Ocular Pharmacology and Therapeutics, 19, 271, 10.1089/108076803321908392 · doi:10.1089/108076803321908392
  146. Bartlett, 2000, Safety and tolerability of pirenzepine ophthalmic gel in pediatric, myopic patients, Investigative Ophthalmology and Visual Science, 41, ARVO E
  147. Bartlett, 2003, Electronic monitoring system to assess patient adherence in pediatric drug studies, Investigative Ophthalmology and Visual Science, 44, ARVO E
  148. Cotter, 2003, Pirenzepine 2% ophthalmic gel retards myopia progression in 8- to 12-year-old children, Optometry, 74, 382
  149. Kwon S Cotter S Chu R Flores Y Safety and efficacy of 2% pirenzepine ophthalmic gel in children with myopia: year two American Academy of Optometry 2001 144 · doi:10.1097/00006324-200112001-00222
  150. Kwon S Cotter S Flores Y Collaborative Assessment of Myopia Progression with pirenzepine (CAMP) study: recruitment underway for FDA (PIR-205) clinical trial American Academy of Optometry 2000 99 · doi:10.1097/00006324-200012001-00154
  151. Siatkowski, 2008, Two-year multicenter, randomized, double-masked, placebo-controlled, parallel safety and efficacy study of 2% pirenzepine ophthalmic gel in children with myopia, Journal of AAPOS, 12, 332, 10.1016/j.jaapos.2007.10.014 · DOI · Paper page
  152. Siatkowski, 2003, Pirenzepine 2% ophthalmic gel retards myopic progression in 8-12 year old children, Investigative Ophthalmology and Visual Science, 44, ARVO E
  153. Siatkowski, 2004, Safety and efficacy of 2% pirenzepine ophthalmic gel in children with myopia: a 1-year, multicenter, double-masked, placebo-controlled parallel study, Ophthalmology, 122, 1667
  154. Siatkowski, 2004, Pirenzepine 2% ophthalmic gel retards myopic progression in 8-12 year old children over two years, Investigative Ophthalmology and Visual Science, 45, ARVO E
  155. Tan, 2003, Pirenzepine ophthalmic gel (PIR): safety and efficacy for pediatric myopia in a one-year study in Asia, Investigative Ophthalmology and Visual Science, 44, ARVO E
  156. Ren, 2017, Effects of low concentration atropine and orthokeratology on myopia prevention and control, International Eye Science, 17, 794
  157. Chan, 2012, Clinical performance of an orthokeratology lens fitted with the aid of a computer software in Chinese children, Contact Lens and Anterior Eye, 35, 180, 10.1016/j.clae.2012.01.004 · doi:10.1016/j.clae.2012.01.004
  158. Cheung, 2016, Long-term effect of orthokeratology on the anterior segment length, Contact Lens and Anterior Eye, 39, 262, 10.1016/j.clae.2016.02.003 · doi:10.1016/j.clae.2016.02.003
  159. Cheung, 2013, Validity of axial length measurements for monitoring myopic progression in orthokeratology, Investigative Ophthalmology and Visual Science, 54, 1613, 10.1167/iovs.12-10434 · doi:10.1167/iovs.12-10434
  160. Cho, 2011, Orthokeratology for slowing myopic progression: a randomised controlled trial, Contact Lens and Anterior Eye, 34, S2, 10.1016/S1367-0484(11)60010-6 · doi:10.1016/s1367-0484(11)60010-6
  161. Cho, 2017, Protective role of orthokeratology in reducing risk of rapid axial elongation: a reanalysis of data from the ROMIO and TO-SEE studies, Investigative Ophthalmology and Visual Science, 58, 1411, 10.1167/iovs.16-20594 · DOI
  162. Cho, 2012, Retardation of Myopia in Orthokeratology (ROMIO) study: a 2-year randomized clinical trial, Investigative Ophthalmology and Visual Science, 53, 7077, 10.1167/iovs.12-10565 · DOI · Paper page
  163. Lopes-Ferreira, 2021, Ocular and corneal aberrations changes in controlled randomized clinical trial MiSight R Assessment Study Spain (MASS), BMC Ophthalmology, 21, 112, 10.1186/s12886-021-01865-y · doi:10.1186/s12886-021-01865-y
  164. Ruiz-Pomeda, 2019, Light disturbance analysis in the controlled randomized clinical trial MiSight® Assessment Study Spain (MASS), Contact Lens and Anterior Eye, 42, 200, 10.1016/j.clae.2018.11.006 · doi:10.1016/j.clae.2018.11.006
  165. Ruiz-Pomeda, 2018, Binocular and accommodative function in the controlled randomized clinical trial MiSight Assessment Study Spain (MASS), Graefes Archives of Clinical and Experimental Ophthalmology, 257, 207, 10.1007/s00417-018-4115-5 · doi:10.1007/s00417-018-4115-5
  166. Ruiz-Pomeda, 2018, MiSight assessment study Spain: adverse events, tear film osmolarity, and discontinuations, Eye and Contact Lens, 44 Suppl 2, S180, 10.1097/ICL.0000000000000484 · doi:10.1097/icl.0000000000000484
  167. Ruiz-Pomeda, 2018, MiSight Assessment Study Spain (MASS). A 2-year randomized clinical trial, Graefes Archives of Clinical and Experimental Ophthalmology, 256, 1011, 10.1007/s00417-018-3906-z · doi:10.1007/s00417-018-3906-z
  168. Ruiz-Pomeda, 2021, Rebound effect in the Misight Assessment Study Spain (MASS), Current Eye Research, 46, 1223, 10.1080/02713683.2021.1878227 · doi:10.1080/02713683.2021.1878227
  169. Donovan, 2012, Myopia progression in Chinese children is slower in summer than in winter, Optometry and Vision Science, 89, 1196, 10.1097/OPX.0b013e3182640996 · DOI
  170. Sankaridurg, 2013, Adverse events during 2 years of daily wear of silicone hydrogels in children, Optometry and Vision Science, 90, 961, 10.1097/OPX.0000000000000017 · doi:10.1097/opx.0000000000000017
  171. Sankaridurg, 2010, Spectacle lenses designed to reduce progression of myopia: 12-month results, Optometry and Vision Science, 87, 631, 10.1097/OPX.0b013e3181ea19c7 · DOI · Paper page
  172. Sankaridurg, 2011, Decrease in rate of myopia progression with a contact lens designed to reduce relative peripheral hyperopia: one-year results, Investigative Ophthalmology and Visual Science, 52, 9362, 10.1167/iovs.11-7260 · DOI · Paper page
  173. Sankaridurg P Bakaraju RC Naduvilath T Chen X Weng R Tilia D Myopia control with novel central and peripheral plus contact lenses and extended depth of focus contact lenses: 2 year results from a randomised clinical trial Ophthalmic and Physiological Optics 2019 39 4 294 307 · doi:10.1111/opo.12621
  174. Schwartz, 1974, A monozygotic cotwin control study of a treatment for myopia, Acta Geneticae Medicae et Gemellologiae, 23, 26, 10.1017/S1120962300022678 · doi:10.1017/s1120962300022678
  175. Schwartz, 1976, A monozygotic co-twin control study of a treatment for myopia, Acta Geneticae Medicae et Gemellologiae, 25, 133, 10.1017/S0001566000013994 · doi:10.1017/s0001566000013994
  176. Schwartz, 1980, Results of a monozygotic co-twin control study on a treatment for myopia, Acta Geneticae Medicae et Gemellologiae, 29, 30
  177. Schwartz, 1981, Results of a monozygotic co-twin control study on a treatment for myopia, Progress in Clinical and Biological Research, Pt C, 249
  178. Chen, 1997, The effect of different concentrations of atropine on myopia controlling in myopic children, Investigative Ophthalmology and Visual Science, 38, S4537
  179. Shih, 1999, Effects of different concentrations of atropine on controlling myopia in myopic children, Journal of Ocular Pharmacology and Therapeutics, 15, 85, 10.1089/jop.1999.15.85 · DOI · Paper page
  180. Berntsen, 2013, Peripheral defocus and myopia progression in myopic children randomly assigned to wear single vision and progressive addition lenses, Investigative Ophthalmology and Visual Science, 54, 5761, 10.1167/iovs.13-11904 · DOI
  181. Berntsen, 2011, Study of Theories About Myopia Progression (STAMP) design and baseline data, Optometry and Vision Science, 87, 823, 10.1097/OPX.0b013e3181f6f776 · doi:10.1097/opx.0b013e3181f6f776
  182. Berntsen, 2010, The effect of bifocal add on accommodative lag in myopic children with high accommodative lag, Investigative Ophthalmology and Visual Science, 51, 6104, 10.1167/iovs.09-4417 · doi:10.1167/iovs.09-4417
  183. Berntsen, 2012, A randomized trial using progressive addition lenses to evaluate theories of myopia progression in children with a high lag of accommodation, Investigative Ophthalmology and Visual Science, 53, 640, 10.1167/iovs.11-7769 · doi:10.1167/iovs.11-7769
  184. Swarbrick, 2011, Overnight orthokeratology for myopia control: short-term effects on axial length and refractive error, Contact Lens and Anterior Eye, 34, S3, 10.1016/S1367-0484(11)60012-X · doi:10.1016/s1367-0484(11)60012-x
  185. Swarbrick, 2015, Myopia control during orthokeratology lens wear in children using a novel study design, Ophthalmology, 122, 620, 10.1016/j.ophtha.2014.09.028 · DOI · Paper page
  186. Tan, 2012, Author reply: one-year multicenter, double-masked, placebo-controlled, parallel safety and efficacy study of 2% pirenzepine ophthalmic gel in children with myopia, Ophthalmology, 119, 2653, 10.1016/j.ophtha.2012.07.018 · doi:10.1016/j.ophtha.2012.07.018
  187. Tan, 2003, Pirenzepine ophthalmic gel (PIR): safety and efficacy for pediatric myopia in a one-year study in Asia, Investigative Ophthalmology and Visual Science, 44, ARVO E
  188. Tan, 2005, One-year multicenter, double-masked, placebo-controlled, parallel safety and efficacy study of 2% pirenzepine ophthalmic gel in children with myopia, Ophthalmology, 112, 84, 10.1016/j.ophtha.2004.06.038 · DOI · Paper page
  189. Tan, 2020, One-year results of 0.01% atropine with orthokeratology (AOK) study: a randomised clinical trial, Ophthalmic and Physiological Optics, 40, 557, 10.1111/opo.12722 · doi:10.1111/opo.12722
  190. Tang, 2021, Effect of orthokeratology on relative peripheral refraction in adolescent myopia, International Eye Science, 21, 734
  191. Trier, 2008, Systemic 7-methylxanthine in retarding axial eye growth and myopia progression: a 36-month pilot study, Journal of Ocular Biology, Diseases, and Informatics, 1, 85, 10.1007/s12177-008-9013-3 · DOI
  192. Trier, 2007, Effect of 7-methylxanthine on axial eye growth in myopic children—24 months follow-up, Investigative Ophthalmology and Visual Science, 48, ARVO E
  193. Trier, 2008, Effect of 7-methylxanthine on eye growth in myopic children—36 months follow-up, Investigative Ophthalmology and Visual Science, 49, ARVO E
  194. Wang, 2017, Atropine 0.5% eyedrops for the treatment of children with low myopia: a randomized controlled trial, Medicine, 96, e7371, 10.1097/MD.0000000000007371 · doi:10.1097/md.0000000000007371
  195. Wei, 2020, Safety and efficacy of low-dose atropine eyedrops for the treatment of myopia progression in Chinese children: a randomized clinical trial, JAMA Ophthalmology, 138, 1178, 10.1001/jamaophthalmol.2020.3820 · doi:10.1001/jamaophthalmol.2020.3820
  196. Lan, 2006, The effectiveness of progressive additional lens on Chinese juvenile-onset acquired myopia: the first year report, Ophthalmic and Physiological Optics, 26, 8
  197. Yang, 2009, The effectiveness of progressive addition lenses on the progression of myopia in Chinese children, Ophthalmic and Physiological Optics, 29, 41, 10.1111/j.1475-1313.2008.00608.x · DOI
  198. Yen, 1989, Comparison of the effect of atropine and cyclopentolate on myopia, Annals of Ophthalmology, 21, 180
  199. Yi, 2015, Therapeutic effect of atropine 1% in children with low myopia, Journal of AAPOS, 19, 426, 10.1016/j.jaapos.2015.04.006 · doi:10.1016/j.jaapos.2015.04.006
  200. Zhang, 2021, Controlling anisomyopia in children by orthokeratology: a one-year randomised clinical trial, Contact Lens and Anterior Eye, 46, 101537, 10.1016/j.clae.2021.101537 · doi:10.1016/j.clae.2021.101537

200 of 426 shown

Cited by

See all 164

Metadata

Authors
Lawrenson, J. G., Shah, R., Huntjens, B., Downie, L. E., Virgili, G., Dhakal, R., Verkicharla, P. K., Li, D., Mavi, S., Kernohan, A., Li, T., & Walline, J. J.
Venue
Cochrane Database of Systematic Reviews
Publisher
Wiley
Published
2023-02-16
Volume
2023
Issue
2
Pages
CD014758-CD014758
ISSN
  • 1361-6137 (ISSN-L)
  • 1465-1858
OpenAlex
W4321087787
Cited by
164
References
10
FWCI
8.77
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.